4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-21-017675
President & CEO sold 1,024 shares at $55.19 ($56,515)
- President & CEO acquired 26,515 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simon, Christopher President & CEO | 2021-05-18 | Grant or award | +26,515 | 196,745 | D: show line 1 in the form | ||
| Simon, Christopher President & CEO | 2021-05-19 | Sale | −1,024 | $55.19 | $56,515 | 195,721 | D: show line 2 in the form |
| Open-market sales · 1,024 sh · avg $55.19 · $56,515 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Simon, Christopher President & CEO | 2021-05-18 | Grant or award · Non-qualified Stock Option (Right to Buy) | +71,733 | 71,733 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…